Poggi A, Pardi R, Pella N, Morelli L, Sivori S, Vitale M, Revello V, Moretta A, Moretta L
Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Eur J Immunol. 1993 Oct;23(10):2454-63. doi: 10.1002/eji.1830231012.
The TA218 and T205 monoclonal antibodies (mAb) were selected on the basis of their ability to inhibit the non-major histocompatibility complex-restricted lysis of the murine mastocytoma P815 cell line mediated by CD3-CD16+ natural killer (NK) cells. Both mAb were found to react with CD45 molecules, as demonstrated by immunoprecipitation after surface iodination and western blot analysis. A panel of tumor target cells susceptible to lysis by polyclonal or clonal CD3-CD16+ NK cells was used to study the mAb-mediated inhibitory effect. The inhibition of cytolysis mediated by TA218 and T205 mAb was found to consistently parallel the inhibition mediated (with the same tumor target cells) by the anti-LFA1 alpha mAb TS.1.22 or by the anti-LFA1 beta mAb TS.1.18. However, different from the anti-LFA1 mAb, T205 or TA218 mAb did not inhibit the binding of activated CD3-CD16+ effector NK cells to the same tumor target cells. This finding supported the concept that the anti-CD45 mAb-mediated inhibition could occur at a post-binding stage. In polyclonal or clonal CD3-CD16+ NK cells T205 or TA218 mAb were found to reduce by 50-70% the intracellular Ca++ ([Ca++]i) mobilization induced by anti-LFA1 alpha or anti-LFA1 beta mAb. On the other hand, TA218 and T205 mAb did not inhibit the Ca++ mobilization induced by anti-CD16 mAb or phytohemagglutinin, thus suggesting that, in NK cells, CD45 molecules may exert a selective inhibitory effect on the signal transduction mediated by LFA1 molecules. In line with this hypothesis, the cytolytic activity of human NK clones was triggered in the presence of the hybridoma cells secreting either anti-CD16 or anti-LFA1 alpha mAb (as "triggering targets"). This effect of anti-LFA1 alpha, but not of anti-CD16 hybridoma was susceptible to inhibition by the anti-CD45 mAb T205 or TA218. Further, experiments on cloned NK cells indicated that T205 or TA218 mAb induced a strong decrease in the constitutive phosphorylation of the LFA1 alpha chain (but not of HLA class I antigens). Taken together, these studies suggest that in human NK lymphocytes, CD45 molecule may regulate both the activation state and the function of the LFA1 molecule.
TA218和T205单克隆抗体(mAb)是根据其抑制由CD3 - CD16 +自然杀伤(NK)细胞介导的小鼠肥大细胞瘤P815细胞系非主要组织相容性复合体限制裂解的能力而选择的。通过表面碘化后的免疫沉淀和蛋白质印迹分析表明,这两种单克隆抗体均与CD45分子发生反应。使用一组易被多克隆或克隆的CD3 - CD16 + NK细胞裂解的肿瘤靶细胞来研究单克隆抗体介导的抑制作用。发现TA218和T205单克隆抗体介导的细胞溶解抑制作用始终与抗LFA1α单克隆抗体TS.1.22或抗LFA1β单克隆抗体TS.1.18介导的(针对相同肿瘤靶细胞)抑制作用平行。然而,与抗LFA1单克隆抗体不同,T205或TA218单克隆抗体不抑制活化的CD3 - CD16 +效应NK细胞与相同肿瘤靶细胞的结合。这一发现支持了抗CD45单克隆抗体介导的抑制作用可能发生在结合后阶段的概念。在多克隆或克隆的CD3 - CD16 + NK细胞中,发现T205或TA218单克隆抗体可使抗LFA1α或抗LFA1β单克隆抗体诱导的细胞内Ca++([Ca++]i)动员减少50 - 70%。另一方面,TA218和T205单克隆抗体不抑制抗CD16单克隆抗体或植物血凝素诱导的Ca++动员,因此表明,在NK细胞中,CD45分子可能对由LFA1分子介导的信号转导发挥选择性抑制作用。与这一假设一致,人NK克隆的细胞溶解活性在分泌抗CD16或抗LFA1α单克隆抗体的杂交瘤细胞(作为“触发靶标”)存在的情况下被触发。抗LFA1α而非抗CD16杂交瘤的这种作用易被抗CD45单克隆抗体T205或TA218抑制。此外,对克隆NK细胞的实验表明,T205或TA218单克隆抗体可使LFA1α链(而非HLA I类抗原)的组成性磷酸化显著降低。综上所述,这些研究表明,在人NK淋巴细胞中,CD45分子可能调节LFA1分子的活化状态和功能。